Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors

BingHe Xu,YiLong Wu, Lin Shen,DingWei Ye,Annette Jappe,Azzeddine Cherfi,Hui Wang,RuiRong Yuan

Journal of Hematology & Oncology（2011）

Cited 26|Views7
No score
Abstract
This phase I, randomized, multicenter, open-label study investigated the pharmacokinetics, safety, and efficacy of the oral mammalian target of rapamycin inhibitor everolimus in Chinese patients with advanced solid tumors.
More
Translated text
Key words
Renal Cell Carcinoma,Everolimus,Chinese Patient,Advanced Solid Tumor,Dose Cohort
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined